Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?

Archives of Internal Medicine

Volumn 158, Issue 5, 1998, Pages 522-527

  Stosor, Valentina ^a   Peterson, Lance R ^a   Postelnick, Michael ^b   Noskin, Gary A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0032498719     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.5.522     Document Type: Article

References (27)

1. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173-1178.
2. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev. 1990;3: 46-65.
3. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis. 1995;20:296-301.
4. Mackowiak PA. The enterococci: evidence of species-specific clinical and microbiologic heterogeneity. Am J Med Sci. 1989;297:238-243.
5. Hoffmann SA, Moellering RC Jr. The enterococcus: 'putting the bug in our ears.' Ann Intern Med. 1987;106:757-761.
6. Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis. 1989;11:74-85.
7. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319:157-161.
8. Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992; 13:700-705.
9. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992; 13:195-200.
10. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342:76-79.
11. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280-1285.
12. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994;38:1363-1367.
13. Handwerger S, Racher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1992;16:750-755.
14. Uttley AH, Woodford N, Johnson AP, Cookson B, George RC. Vancomycin-resistant enterococci. Lancet. 1993;342:615.
15. Wade J, Rolando N, Casewell M. Resistance of Enterococcus faecium to vancomycin and gentamicin. Lancet. 1991;337:1616.
16. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-116.
17. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993; 42:597-599.
18. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple anti-microbial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123:250-259.
19. Noskin GA, Postelnick M, Peterson LR. Control of enterococci by restriction of third generation cephalosporins. Clin Infect Dis. 1994;19:597.
20. Bodnar UR, Noskin GA, Suriano T, Cooper I, Reisberg BE, Peterson LR. Use of in-house molecular epidemiology and full species identification for controlling spread of vancomycin resistant Enterococcus faecalis isolates. J Clin Microbiol. 1996;34:2129-2132.
21. Lam S, Siger C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control. 1995;23:170-180.
22. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991; 115:585-590.
23. Facklam RR, Collins MD. Identification of enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27:731-734.
24. National Committee for Clinical Laboratory Standards. Methods for Dilution: Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1997. NCCLS document M7-A4.
25. Linden PK, Pasculle AW, Manez R, et al. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible Enterococcus faecium. Clin Infect Dis. 1996;22:663-670.
26. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med. 1996;156:1458-1462.
27. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis. 1995;21:45-50.